文献速递腹部US

良性肝脏病变的超声造影

Contrast-enhanced ultrasound of benign liver lesions.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

良性肝脏病变常在超声检查中偶然发现且可能定性不完整,需进一步影像检查。美国食品药品监督管理局近期批准超声造影用于肝脏病变定性,超声造影能定性局灶性肝脏病变,在检测肿瘤血管方面优于彩色多普勒和能量多普勒超声。本文综述良性肝脏病变的超声造影成像特征,包括肝囊肿、血管瘤、局灶性脂肪、局灶性结节性增生、肝细胞腺瘤、脓肿和外伤性病变。

要点

  • 超声造影已获美国食品药品监督管理局批准用于肝脏病变定性。
  • 超声造影在检测肿瘤血管方面优于彩色多普勒和能量多普勒超声。
  • 鉴别良恶性肝脏病变是肝脏病变定性的关键。

核心结论

  • 本文综述良性肝脏病变的超声造影成像特征,包括肝囊肿、血管瘤、局灶性脂肪、局灶性结节性增生、肝细胞腺瘤、脓肿和外伤性病变。

研究设计与样本

  • 综述;检索范围与纳入文献原文未报告。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Liver lesions are often incidentally detected on ultrasound examination and may be incompletely characterized, requiring further imaging. Contrast-enhanced ultrasound (CEUS) was recently approved by the Food and Drug Administration in the United States for liver lesion characterization. CEUS has the ability to characterize focal liver lesions and has been shown to be superior to color Doppler and power Doppler ultrasound in the detection of tumor vascularity. Differentiating benign from malignant liver lesions is essential to characterizing liver lesions. The CEUS imaging characteristics of benign liver lesions are reviewed, including hepatic cysts, hemangiomas, focal fat, focal nodular hyperplasia, hepatocellular adenomas, abscesses, and traumatic lesions.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Zarzour JG, Porter KK, Tchelepi H, et al. Contrast-enhanced ultrasound of benign liver lesions. Abdom Radiol (NY). 2018. PMID: 29167944. doi:10.1007/s00261-017-1402-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。